Generics and Biosimilars Initiative Journal
Published/Hosted by Pro Pharma Communications International.
ISSN (printed): 2033-6403. ISSN (electronic): 2033-6772.
The mission of GaBI Journal is to provide an independent, high quality, authoritative and peer reviewed platform for the publication of scientific articles concerning the research into and development of cost-effective medicines, irrespective of their source. GaBI Journal aims to make information on pharmaceutical innovation and developments in generic and biosimilar medicines accessible to everyone, including physicians, pharmacists and nurses, patients/consumers, drug developers, third-party payers, legislators and assessors. The scope of GaBI Journal is broad and of interest and relevance to professionals active in clinical practice, pharmaceutical science and policy. Materials published in the journal include high quality research reports, literature reviews, and case studies.
- Further information
- Category Link